Blood, Vol 132, Issue 7

Blood Vol 132, Issue 7 "Aggressive B-cell lymphomas in patients with myelofibrosis receiving JAK1/2 inhibitor therapy"

Sabrina Tripolt's and Andrea Hölbl-Kovacic's cooperation regarding JAK2 inhibitors with Meduni Vienna (Porpaczy et al.) was chosen as the cover article of Blood, Volume 132, Issue 7!

Link to press release of publication 3

Link to article in Blood 4


see full news archive 1




Welcome to the Institute of Pharmacology and Toxicology




Our mission is to discover molecular mechanisms underlying physiological and pathophysiological processes in the organism. This approach is the base for rational drug design, it serves target identification and target validation in modern pharmacological research. Thereby our research offers hope for defeating some of humanity's most devastating diseases-- cancer. The mission of the institute is to perform research and education in molecular, cellular, and clinical pharmacology.

Modern medicine relies on the correct, precise use of drugs. The development of novel therapeutics over the last decades enabled us to cure a wide range of diseases. Yet many aspects still prove difficult and are awaited to be solved! The greatest challenge of our time is to translate the knowledge gathered in this post-genomic era into practice for patient-tailored treatment options - a concept termed as Personalised or Precision Medicine. Pharmacology is not only committed to find out the mechanism of action of drugs but also assists in preparing and understanding how modern drugs can be optimally exploited for the benefit of each patient in the future.

Curriculum Vitae of Veronika Sexl 6

Research 7

Publications 8


Recent publications


Sofie Nebenfür, Florian Bellutti and Veronika Sexl
Cdk6: At the interface of Rb and p53 9
Journal: Molecular & Cellular Oncology


Florian Bellutti, Veronika Sexl, et al.
CDK6 Antagonizes p53-Induced Responses during Tumorigenesis 10
Journal: Cancer Discovery


Agnieszka Witalisz-Siepracka, Dagmar Gotthardt, et al.
NK cell-specific CDK8 deletion enhances antitumor responses 11
Journal: Cancer Immunology Research



Office: Mon. - Fri. 08:00-14:00

Student affairs: Mon. and Wed. 09:00-11:00

Tel: +43 1 25077 2901
Fax: +43 1 25077 2990
Email: Secretariat

Postal address:

Veterinary University of Vienna
Institute of Pharmacology and Toxicology
Veterinärplatz 1
1210 Vienna

Building HA, 3rd floor

Link to directions 12


Appointment with Veronika Sexl only after prior agreement per email: veronika.sexl(at)vetmeduni.ac.at